Evidence map›Paper›PMID 28500179›Full record

ArticleCirculation. Arrhythmia and electrophysiology2017

Is TGF-β

Kuljeet Kaur, José Jalife

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation. Arrhythmia and electrophysiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Cardiac Immunology: A New Era for Immune Cells in the Heart.Advances in experimental medicine and biology · 2021
    Review
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Kuljeet KaurFrom the Department of Internal Medicine, Center for Arrhythmia Research, University of Michigan, Ann Arbor (K.K., J.J.); Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (J.J.); and Centro de Investigación Biomédica en Red, Enfermedades Cardiovasculares, Spain (J.J.).
José JalifeFrom the Department of Internal Medicine, Center for Arrhythmia Research, University of Michigan, Ann Arbor (K.K., J.J.); Centro Nacional de Investigaciones Cardiovasculares Carlos III, Madrid, Spain (J.J.); and Centro de Investigación Biomédica en Red, Enfermedades Cardiovasculares, Spain (J.J.). jjalife@umich.edu.

Funding

Intermolecular Interactions of NaV1.5 and Kir2.1 In Ion Channel DiseasesR01HL122352 · NHLBI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI BERENFELD, OMER · 2015 to 2018
$1.9M
NHLBI NIH HHS R01 HL122352
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MyofibroblastsTransforming Growth Factor beta1Arrhythmias, CardiacFibroblastsHumansMyocytes, CardiacTransforming Growth FactorsTransforming Growth Factor beta1Transforming Growth FactorsarrhythmiacardiomyopathiesEditorialselectrophysiologyfibroblastsmyofibroblastsremodeling

Identifiers

PMID28500179
PMCPMC5508726

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.